Skip to main content
. 2023 Nov 13;38(1):2277135. doi: 10.1080/14756366.2023.2277135

Table 3.

Anti-influenza virus activity and cytotoxicity of selected compounds in MDCK cells.

Inline graphic
    EC50 a values (μM) towards influenza viruses
 
Compounds. R H1N1 c H3N2 d CC50 (μM) b
    group-1 group-2  
6g graphic file with name IENZ_A_2277135_ILG0029.jpg 0.03 ± 0.03 0.16 ± 0.08 >250
6i graphic file with name IENZ_A_2277135_ILG0030.jpg 0.03 ± 0.03 0.32 ± 0.08 >250
6j graphic file with name IENZ_A_2277135_ILG0031.jpg 0.03 ± 0.02 0.80 ± 0.003 >250
6k graphic file with name IENZ_A_2277135_ILG0032.jpg 0.02 ± 0.01 0.12 ± 0.03 >250
OSC 0.02 ± 0.01 0.36 ± 0.16 >250
ZA 0.009 ± 0.002 0.27 ± 0.03 >250

aEC50: compound concentration that inhibits 50% of virus plaque formation in MDCK cells infected with influenza A viral strains, presented as the mean ± SD and determined by the PRA method.

bCC50: concentration required to reduce the viability of mock-infected cell cultures by 50%, as determined by the MTT method.

cA/PR/8/34.

dA/Wisconsin/67/05.